The NMRA has identified a shortage of Lignocaine Throat Spray in the country. In order to ensure continued availability of this essential medicine for patients, NMRA will be accepting and evaluating product registration applications for Lignocaine Throat Spray with immediate effect.

Applicants are kindly requested to:

·       Submit complete dossiers in accordance with the applicable regulatory guidelines.

·       Ensure that product quality, safety, and efficacy data are provided as per NMRA requirements.

All submissions will be subject to the standard regulatory review process with priority attention due to the shortage situation.

For further information or clarification, applicants may contact the Medicines Regulatory Division, NMRA.

‍